z-logo
open-access-imgOpen Access
Influence of PON1 Polymorphisms on the Association between Serum Paraoxonase 1 and Homocysteinemia in a General Population
Author(s) -
Michelle M. Murphy,
Judit Marsillach,
Jordi Camps,
Joan FernándezBallart,
Bharti Mackness,
Michael I. Mackness,
Natàlia Ferré,
Jorge Joven
Publication year - 2006
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2005.064212
Subject(s) - pon1 , paraoxonase , homocysteine , aryldialkylphosphatase , hyperhomocysteinemia , medicine , endocrinology , methionine , chemistry , oxidative stress , biochemistry , biology , gene , genotype , amino acid
Homocysteine (Hcy)-induced vascular impairment may be partially mediated by the production of Hcy thiolactone (HTL). This compound acylates side-chain lysine groups in proteins and alters protein structure and function. HTL is formed under conditions of high Hcy resulting from insufficient remethylation of Hcy to methionine; however, HTL is not a reliable marker of plasma total Hcy (tHcy). In healthy volunteers, it contributes only 0.14%–0.28% of tHcy, has a half-life of 1 h, and is below the detection limit in approximately one half of volunteers (1).Paraoxonase 1 (PON1) is a hydrolase associated with HDL that is thought to degrade lipid peroxides and HTL (2). Decreased PON1 activity has been associated with atherosclerosis (3). Hepatic expression of the PON1 gene is down-regulated in hyperhomocysteinemic mice (4); it is plausible, therefore, that the proatherogenic effects of Hcy may involve diminished serum PON1 activity, leading to impaired antioxidant function and …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom